Lezack Adam 4
4 · Beta Bionics, Inc. · Filed Nov 5, 2025
Insider Transaction Report
Form 4
Lezack Adam
Director
Transactions
- Sale
Common Stock
2025-10-31$26.85/sh−1,368$36,727→ 9,879 total - Sale
Common Stock
2025-10-31$27.70/sh−38$1,053→ 9,841 total
Footnotes (2)
- [F1]Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025.
- [F2]The weighted average sale price for the transaction reported was $26.8474 and the range of prices were between $26.27 and $27.24. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.